House Introduces Bill to Expand Federal Lyme Disease Research and Response
/ 1 min read
Table of Contents
A bill titled the Stamp Out Lyme Disease Act was introduced in the U.S. House of Representatives. The legislation has been referred to the Committee on Oversight and Government Reform and the Committee on Energy and Commerce for review.
Why it matters: This is a standard legislative introduction. Until a bill passes both chambers and is signed, it changes nothing. However, it signals that members of Congress are prioritizing Lyme disease as a public health issue, which may influence future budget discussions or agency rulemaking.
Who it affects
- Patients and families dealing with Lyme disease
This action is recorded by Congress.gov; readers should check the full bill text for specific policy details before relying on this summary.
Agency: House
Source: Congress.gov — read the official document